American Journal of Translational Research·Nov 15Protective effects of SS-31 against SDHB suppression-mitochondrial dysfunction-EndMT axis-modulated CBT sclerosis and progressionStudy in peopleElamipretidePaper
Clocks & Sleep·Oct 23Adverse Neurological Effects of Short-Term Sleep Deprivation in Aging Mice Are Prevented by SS31 PeptideExperiments in miceElamipretidePaper
Frontiers in Cellular Neuroscience·Aug 13Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged MiceExperiments in miceElamipretidePaper
Aging Cell·Aug 12SS-31 and NMN: Two paths to improve metabolism and function in aged heartsExperiments in miceElamipretidePaper
Biomedicine & Pharmacotherapy·Jul 24Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathwayExperiments in 32 miceElamipretidePaper
eLife·Jul 11Late-life restoration of mitochondrial function reverses cardiac dysfunction in old miceExperiments in miceDiastolic dysfunctionPaper
Biogerontology·May 25Targeting reactive oxygen species (ROS) to combat the age-related loss of muscle mass and functionReviewMusclePaper
The Journal of Biological Chemistry·Apr 9The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of actionExperiments in cellsMitochondrionPaper
Journal of Cachexia, Sarcopenia and Muscle·Feb 1Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia ConferenceReviewCachexiaPaper
bioRxiv·Jan 3Reduction of Elevated Proton Leak Rejuvenates Mitochondria in the Aged CardiomyocytePreprint: experiments in miceInterventionsPaper
Journal of Neuroinflammation·Nov 20Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in miceExperiments in miceElamipretidePaper
Frontiers in Pharmacology·Nov 8Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH₂) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney InjuryExperiments in miceElamipretidePaper
Biochemical and Biophysical Research Communications·Oct 1SS-31 reduces inflammation and oxidative stress through the inhibition of Fis1 expression in lipopolysaccharide-stimulated microgliaExperiments in mouse cellsElamipretidePaper
Acta Biochimica et Biophysica Sinica·Apr 1Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma modelExperiments in ratsElamipretidePaper
Cellular Physiology and Biochemistry·Mar 26Mitochondrial Protection Partly Mitigates Kidney Cellular Senescence in Swine Atherosclerotic Renal Artery StenosisExperiments in 6 pigsKidneyPaper
Journal of Cachexia, Sarcopenia and Muscle·Feb 1Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia ConferenceReviewCachexiaPaper
ESC Heart Failure·Jan 28Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failureExperiments in dogsElamipretidePaper
Free Radical Biology & Medicine·Jan 1Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged miceExperiments in miceElamipretidePaper
Protein and Peptide Letters·Nov 2Stealth Peptides Target Cellular Powerhouses to Fight Rare and Common Age-Related DiseasesReviewInterventionsPaper
Archives of Biochemistry and Biophysics·Oct 26Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during agingReviewInterventionsPaper
Scientific Reports·Oct 22The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetesCase-control study of 57 peopleElamipretidePaper
Oxidative Medicine and Cellular Longevity·Aug 27SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain InjuryExperiments in miceElamipretidePaper
Biomaterials Science·May 29Novel SS-31 modified liposomes for improved protective efficacy of minocycline against drug-induced hearing lossExperiments in zebrafishElamipretidePaper
Journal of Physiology and Biochemistry·Mar 27Protective effects of mitochondrion-targeted peptide SS-31 against hind limb ischemia-reperfusion injuryExperiments in miceElamipretidePaper
Aging Cell·Feb 7Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged miceExperiments in miceElamipretidePaper
Journal of Cachexia, Sarcopenia and Muscle·Feb 1Silver linings on the horizon: highlights from the 10th Cachexia ConferenceReviewCachexiaPaper
Circulation Heart Failure·Dec 1Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of ElamipretideRandomized trial in 12 peopleElamipretidePaper
Circulation Cardiovascular Interventions·Sep 1Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery StenosisRandomized trial in 8 peopleElamipretidePaper
Scientific Reports·Aug 29Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxiaExperiments in human cellsElamipretidePaper
European Heart Journal Acute Cardiovascular Care·May 23The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarctionNon-randomized trial in 19 peopleElamipretidePaper